Latest Data on Immunotherapy for dMMR/MSI-H CRC

Total Health

A. Grothey

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

ASCO GI 2023 CTCs as Liquid Biopsies in Patients With mCRC vs. Other…

ASCO GI 2023 Conference Coverage

P. Kasi

Ongoing GI Oncology Trials at Yale

Yale Cancer Center

P. Kunz, M. Cecchini, J. Lacy

Personalized Treatment for Metastatic CRC

Yale Cancer Center

M. Cecchini

Advances in Hepatocellular Carcinoma Diagnosis and Treatment

Scripps Health

A. Singal

mCRC Case Discussion: Treatment Options for Unresectable Liver Metas…

Yale Cancer Center

P. Kunz, J. Kortmansky, L. Baum, K. Du, S. Khan

Surgical Management of Colorectal Cancer for Gastroenterologists

UCSF School of Medicine

M. Varma

Lecture Summary - ASCO 2022 on the Phase 2/3 Study of an Individuali…

ASCO 2022 Conference Coverage

J. Hecht

ASCO® GI 2024 Insights: "Bi-Weekly FTD/TPI + Bevacizumab vs. FTD/TPI…

Insights from 2024 ASCO® GI Annual Meeting

H. Satake

Management of IBD in Patients With Malignancy

Stanford Medicine

S. Singh

Colon Cancer Screening: Updates for 2024

Houston Methodist

N. Mathur

Biomarker Testing Prior to Therapy Initiation in mCRC

Mark Lewis

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

Treatment of mCRC After Standard Chemotherapy

UChicago Medicine

A. Shergill

Treatment Options for Patients With Lynch Syndrome & CRC

University of Colorado Cancer Center

C. Lieu

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ESMO 2022 on the Global Phase 3 Multiregional Clinical Trial FRESCO-…

ESMO 2022 Conference Coverage

A. Dasari

ASCO GI 2023 Continuous Maintenance Capecitabine Dosing for Advanced…

ASCO GI 2023 Conference Coverage

R. Mukherji

ERASur: A Ph3 Study of Total Ablative Therapy for Limited mCRC (A022…

Eric Miller

P. Romesser